Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15955161 | 1.00 | ALDH1A1 (0.38) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL15965435 | 1.00 | ALDH1A1 (0.38) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL8937095 | 1.00 | ALDH1A1 (0.38) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL15965436 | 0.92 | ALDH1A1 (0.33) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL15965432 | 0.92 | ALDH1A1 (0.33) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL3822615 | 0.86 | ALDH1A1 (0.39) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL13566357 | 0.81 | ALDH1A1 (0.36) | ALDH1A1KCNH2MEN1KMT2APKM | |
| SCHEMBL12921569 | 0.80 | KCNH2 (0.33) | KCNH2MEN1KMT2ADHFRGPR35 | |
| SCHEMBL5949101 | 0.80 | KCNH2 (0.33) | KCNH2MEN1KMT2ADHFRGPR35 | |
| SCHEMBL18750419 | 0.80 | ALDH1A1 (0.31) | ALDH1A1GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9611233-B2 | Organic compound | CANON KABUSHIKI KAISHA (JP) | 2017-04-04 | — | — | US | disclosed |
| US-9611233-B2 | Organic compound | CANON KABUSHIKI KAISHA (JP) | 2017-04-04 | — | — | US | disclosed |
| US-20160152633-A1 | NOVEL ORGANIC COMPOUND | CANON KK (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160152633-A1 | NOVEL ORGANIC COMPOUND | CANON KK (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-2719702-B1 | ELECTROCHROMIC ELEMENT | CANON KK (JP) | 2016-05-11 | — | — | EP | disclosed |
| US-9284328-B2 | Organic compound | CANON KABUSHIKI KAISHA (JP) | 2016-03-15 | — | — | US | disclosed |
| US-20150031894-A1 | NOVEL ORGANIC COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2015-01-29 | — | — | US | disclosed |
| US-20150031894-A1 | NOVEL ORGANIC COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2015-01-29 | — | — | US | disclosed |
| EP-2719702-A1 | ELECTROCHROMIC ELEMENT | Canon Kabushiki Kaisha (JP) | 2014-04-16 | — | — | EP | disclosed |
| US-7709829-B2 | Organic semiconductor material, organic transistor, field effect transistor, switching device and thiazole compound | KONICA MINOLTA HOLDINGS, INC. (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20080251784-A1 | Organic Semiconductor Material, Organic Transistor, Field Effect Transistor, Switching Device and Thiazole Compound | EDISON INNOVATIONS LLC | 2008-10-16 | — | — | US | disclosed |
| US-5536808-A | Thiazole polymers and method of producing same | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1996-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031894-A1 | NOVEL ORGANIC COMPOUND | AOX1, AOC2, OXER1 | ALDH1A1 21/4885KCNH2 50/4885MEN1 3650/4885 |
| US-20160152633-A1 | NOVEL ORGANIC COMPOUND | AOX1, AOC2, OXER1 | ALDH1A1 21/4885KCNH2 50/4885MEN1 3650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.